 |
|
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
A Study of Proposed Electrodiagnostic and Histologic Criteria
Rizwan U. Haq, MD;
Timothy J. Fries, MD;
William W. Pendlebury, MD;
Michael J. Kenny, MS;
Gary J. Badger, MS;
Rup Tandan, MD, FRCP
Arch Neurol. 2000;57:1745-1750.
Objective To examine the sensitivity of the 3 proposed electrodiagnostic (EDX) criteria for demyelination, the sensitivity and specificity of the proposed Ad Hoc Subcommittee of the American Academy of Neurology AIDS [Acquired Immunodeficiency Syndrome] Task Force histologic criteria (AAN criteria), the degree of agreement among these criteria, and the diagnostic value of sural nerve histologic criteria in patients with idiopathic chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Design and Methods A retrospective analysis of 24 patients with idiopathic CIDP and 12 patients with diabetic polyneuropathy (DP) who underwent comparable testing of clinical, histologic, and EDX features.
Results We found 42%, 50%, and 79% sensitivity of the proposed EDX, AAN teased fiber, and AAN electron microscopic (EM) criteria, respectively, for demyelination in CIDP. The specificity of the proposed AAN teased fiber and EM criteria for demyelination was greater than 80% when tested against patients with DP. There was lack of agreement between the EDX and histologic criteria. Almost two thirds of patients with CIDP who met the EM criteria but none of the EDX criteria for demyelination showed a favorable response to immunomodulatory therapy.
Conclusions Sural nerve histologic criteria offer unique sensitivity and acceptable specificity toward the diagnosis of CIDP. Sural nerve biopsy should be considered when a clinical suspicion of CIDP remains in patients who do not meet the proposed EDX criteria for demyelination.
From the Departments of Neurology (Drs Haq, Fries, Pendlebury, and Tandan), Pathology (Section of Neuropathology) (Dr Pendlebury), and Medical Biostatistics (Messrs Kenny and Badger), University of Vermont College of Medicine, Burlington.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(12):1794-1795.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
The French CIDP Study Group
Postgrad. Med. J. 2008;84:378-381.
ABSTRACT
| FULL TEXT
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy
The French CIDP Study Group
J. Neurol. Neurosurg. Psychiatry 2008;79:115-118.
ABSTRACT
| FULL TEXT
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy
Tackenberg et al.
Neurology 2007;68:1622-1629.
ABSTRACT
| FULL TEXT
How to get the most out of nerve conduction studies and electromyography
Fuller
J. Neurol. Neurosurg. Psychiatry 2005;76:ii41-ii46.
FULL TEXT
Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37{degrees}C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy
Van Asseldonk et al.
Brain 2005;128:880-891.
ABSTRACT
| FULL TEXT
Chronic Inflammatory Demyelinating Polyneuropathy
Koller et al.
NEJM 2005;352:1343-1356.
FULL TEXT
Comparison of Electrodiagnostic Abnormalities and Criteria in a Cohort of Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Magda et al.
Arch Neurol 2003;60:1755-1759.
ABSTRACT
| FULL TEXT
Research criteria for defining patients with CIDP
Sander and Latov
Neurology 2003;60:S8-15.
ABSTRACT
| FULL TEXT
Case 6-2003 - A Nine-Year-Old Girl with Progressive Weakness and Areflexia
Sander and Hedley-Whyte
NEJM 2003;348:735-743.
FULL TEXT
Diagnosis of CIDP
Latov
Neurology 2002;59:S2-6.
ABSTRACT
| FULL TEXT
|
